BioAdvance Venture Fund

BioAdvance is a leading early-stage life sciences venture fund based in Radnor, Pennsylvania, dedicated to investing in promising healthcare startups in the mid-Atlantic region. Established in 2002 using funds from the Pennsylvania tobacco settlement, the firm provides critical seed and early-stage capital to companies across therapeutics, medical devices, diagnostics, and health IT sectors. Beyond financial investment, BioAdvance offers strategic guidance and access to an extensive network of industry experts to help portfolio companies reach key developmental milestones. To date, the fund has invested over $50 million in more than 100 companies, fostering a robust ecosystem for biotechnology innovation in Southeastern Pennsylvania. The organization's portfolio includes numerous successful exits, highlighting its role as a key driver of regional economic growth in the life sciences.